Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ICONIC LABS PLC Board/Management Information 2019

May 1, 2019

4953_rns_2019-05-01_64a273c3-026d-476c-9248-1efb07eadef6.html

Board/Management Information

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7974X

WideCells Group PLC

01 May 2019

1 May 2019

WideCells Group PLC ('WideCells' or 'the Company)

Corporate Update

WideCells announces that Mr. Peter Presland has stepped down from the Board as a Non-Executive Director with immediate effect in order to pursue his other business interests.  Mr. Presland has been a Director since December 2017, and the Board would like to thank him for his contribution and wishes him well in the future.

The Company also announces that following the change in strategy and the arrival of the Iconic Labs team, it has terminated the engagement of Align Research, again with immediate effect.   

**ENDS**

For further information, please visit the Company's website www.iconiclabs.co.uk or contact:

Shard Capital Partners LLP Joint Broker - Damon Heath & Erik Woolgar Tel: +44 (0) 20 7186 9950
finnCap Ltd Joint Broker - Christopher Raggett Tel: +44 (0) 20 7220 0500
St Brides Partners Limited PR - Melissa Hancock & Juliet Earl Tel: +44 (0) 20 7236 1177

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

BOAZFLFBKEFEBBB